Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
PUT
Eaton
ETN
$169B
| $129M | 0.02% |
387,400
+110,300
| +40% | +$38.7M |
2013 Q2
46 quarters
|
|
602
CALL
Cloudflare
NET
$124B
| $128M | 0.02% |
1,191,100
-275,500
| -19% | -$26.9M |
2019 Q4
20 quarters
|
|
603
PUT
McKesson
MCK
$105B
| $128M | 0.02% |
224,900
+40,600
| +22% | +$22.7M |
2013 Q2
46 quarters
|
|
604
PUT
Gilead Sciences
GILD
$179B
| $128M | 0.02% |
1,387,200
+192,300
| +16% | +$17.3M |
2013 Q2
46 quarters
|
|
605
Vale
VALE
$58.6B
| $128M | 0.02% |
14,401,202
+612,944
| +4% | +$6.24M |
2022 Q3
9 quarters
|
|
606
AbbVie
ABBV
$464B
| $128M | 0.02% |
718,537
+471,342
| +191% | +$86.7M |
2024 Q3
1 quarter
|
|
607
Lowe's Companies
LOW
$101B
| $127M | 0.02% |
516,303
+378,629
| +275% | +$101M |
2021 Q1
15 quarters
|
|
608
CrowdStrike
CRWD
$277B
| $127M | 0.02% |
1,484,000
+1,243,684
| +518% | +$103M |
2019 Q2
22 quarters
|
|
609
Snowflake
SNOW
$120B
| $127M | 0.02% |
821,605
+62,043
| +8% | +$8.74M |
2020 Q3
17 quarters
|
|
610
PUT
C3.ai
AI
$1.77B
| $127M | 0.02% |
3,683,500
+1,044,200
| +40% | +$32.4M |
2020 Q4
16 quarters
|
|
611
Bio-Techne
TECH
$11.4B
| $127M | 0.02% |
1,758,074
+553,590
| +46% | +$40.7M |
2024 Q1
3 quarters
|
|
612
PUT
Nu Holdings
NU
$64.9B
| $126M | 0.02% |
12,151,700
+766,500
| +7% | +$10.2M |
2021 Q4
12 quarters
|
|
613
PUT
Thermo Fisher Scientific
TMO
$242B
| $126M | 0.02% |
241,900
-18,200
| -7% | -$10M |
2013 Q2
46 quarters
|
|
614
Cintas
CTAS
$77.1B
| $126M | 0.02% |
687,779
+307,865
| +81% | +$64.7M |
2015 Q4
36 quarters
|
|
615
CALL
Snap
SNAP
$9.44B
| $125M | 0.02% |
11,633,800
+4,358,400
| +60% | +$49.1M |
2017 Q1
31 quarters
|
|
616
CALL
Intercontinental Exchange
ICE
$84.3B
| $125M | 0.02% |
836,900
+222,200
| +36% | +$35.2M |
2013 Q2
46 quarters
|
|
617
PUT
RH
RH
$2.28B
| $124M | 0.02% |
315,600
-33,100
| -9% | -$11.8M |
2013 Q4
44 quarters
|
|
618
Ecolab
ECL
$76.7B
| $124M | 0.02% |
530,035
+462,820
| +689% | +$115M |
2018 Q4
24 quarters
|
|
619
Teradyne
TER
$70.2B
| $124M | 0.02% |
986,161
+971,567
| +6,657% | +$115M |
2013 Q2
46 quarters
|
|
620
CALL
Kroger
KR
$34.9B
| $124M | 0.02% |
2,029,300
+757,900
| +60% | +$44.5M |
2013 Q2
46 quarters
|
|
621
Viatris
VTRS
$20.2B
| $124M | 0.02% |
9,956,809
+5,733,850
| +136% | +$70.5M |
2021 Q1
15 quarters
|
|
622
PUT
JD.com
JD
$34.8B
| $124M | 0.02% |
3,567,300
-1,808,300
| -34% | -$70M |
2016 Q2
34 quarters
|
|
623
CALL
Yum! Brands
YUM
$37.1B
| $123M | 0.02% |
920,200
-192,000
| -17% | -$26M |
2013 Q2
46 quarters
|
|
624
Ascendis Pharma A/S
ASND
$15B
| $123M | 0.02% |
895,984
+232,060
| +35% | +$30.5M |
2022 Q2
10 quarters
|
|
625
Hilton Worldwide
HLT
$71.9B
| $123M | 0.02% |
495,835
-970,551
| -66% | -$238M |
2023 Q3
5 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.